IMP3 contains two RNA recognition motifs and four K homology domains, which are crucial for its function in binding to RNA. These structural features enable IMP3 to interact with specific mRNA targets, influencing their localization within the cell, their stability, and their translation into proteins .
IMP3 is an oncofetal protein, meaning it is typically expressed during fetal development and in various types of cancer. It plays a significant role in cell growth and development, and its expression is often associated with poor prognosis and metastasis in several cancers . Research has shown that IMP3 is involved in a variety of physiological and pathological processes, including:
The expression of IMP3 has been studied extensively in the context of cancer. It is considered a marker for poor prognosis and metastasis in various cancers, including testicular and melanocytic neoplasia . Additionally, IMP3 has been proposed as a diagnostic marker for differentiating certain types of lymphomas, such as nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) from T cell/histiocyte-rich large B cell lymphoma (THRLBCL) .
IMP3 is widely used in research to study its role in cancer and development. Recombinant IMP3, produced through recombinant DNA technology, is used in various experimental applications, including: